Positioning patient face-down could improve chances of macula hole closure

Article

Positioning patients face down after surgery could improve chances of macula hole closure

Positioning patients face down after surgery could improve chances of macula hole closure, according to a study in the journal Eye.

The randomized, controlled trial, led by Dr J. Bainbridge, included 30 phakic eyes of 30 subjects with idiopathic full-thickness macula holes. Each patient underwent vitrectomy with dye-assisted peeling of the ILM and 14% perfluoropropane gas.

Participants were randomized into two groups. Group 1, the posturing group, were positioned face-down for 10 days and group 2, the non-posturing group, were to avoid a face-up position. The primary measure was anatomical macula hole closure.

The results revealed that macula holes closed in 14 of the 15 eyes in group 1 and in 9 of 15 eyes in group 2. Macula holes smaller than 400μm closed regardless of posturing. In 10 of the 11 remaining group 1 eyes holes larger than 400μm closed and 4 of 10 eyes in group 2.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.